Deutsche Effecten- und Wechsel- Beteiligungsges. AG

M&A Activity • Dec 17, 2002

News Details

Ad-hoc | 17 December 2002 07:25

DEWB AG english

DEWB AG sells its stake in Carl Zeiss Meditec AG Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– DEWB AG sells its stake in Carl Zeiss Meditec AG Merger provided for the successful trade sale. DEWB AG (Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft) has sold its stake in Carl Zeiss Meditec AG. The buyers of the 2.39 million shares, resp. the 9.2 percent stake in the company, are institutional investors. The purchase price will be paid in cash. DEWB has maintained partnership relations with Carl Zeiss Meditec AG and its predecessor companies for a long time. In 1997 DEWB acquired an investment in Aesculap-Meditec GmbH. In March 2000 it floated the company, then operating under the name of Asclepion-Meditec AG, on the stock market. As a major shareholder DEWB assisted the company in its further development – including the merger to create Carl Zeiss Meditec AG in July 2002. Carl Zeiss Meditec is today one of the world’s largest and leading ophthalmic system providers. DEWB has played a decisive part in the merger of the two companies and in this way achieved key objectives: the newly merged company, Carl Zeiss Meditec, now has a size that ensures the stable growth of the company. The increased market capitalisation as well as the company’s new orientation are attracting greater attention to the company in the capital market thus creating the preconditions for selling DEWB’s stake in Carl Zeiss Meditec. Contact: Steffen Schneider, DEWB AG, Investor Relations Telephone / Telefax: ++49 3641 65 22 90 / 65 2157 E-Mail: steffen.schneider@dewb-vc.com, Internet: http://www.dewb-vc.com end of ad-hoc-announcement (c)DGAP 17.12.2002 ——————————————————————————– WKN: 804100; ISIN: DE0008041005; Index: Listed: Amtlicher Markt in Berlin und Frankfurt 170725 Dez 02